Toronto - Delayed Quote CAD

Curaleaf Holdings, Inc. (CURA.TO)

Compare
2.1900 -0.0500 (-2.23%)
At close: December 27 at 4:00:00 PM EST
Loading Chart for CURA.TO
DELL
  • Previous Close 2.2400
  • Open 2.2400
  • Bid 2.1600 x --
  • Ask 2.1900 x --
  • Day's Range 2.1350 - 2.2400
  • 52 Week Range 2.0550 - 8.7300
  • Volume 435,359
  • Avg. Volume 501,240
  • Market Cap (intraday) 1.641B
  • Beta (5Y Monthly) 1.49
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4000
  • Earnings Date Mar 4, 2025 - Mar 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.79

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

www.curaleaf.com

5,650

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CURA.TO

View More

Performance Overview: CURA.TO

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CURA.TO
60.25%
S&P/TSX Composite index
18.31%

1-Year Return

CURA.TO
56.02%
S&P/TSX Composite index
18.75%

3-Year Return

CURA.TO
80.87%
S&P/TSX Composite index
16.80%

5-Year Return

CURA.TO
88.41%
S&P/TSX Composite index
44.33%

Compare To: CURA.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CURA.TO

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    1.64B

  • Enterprise Value

    2.73B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    1.19

  • Enterprise Value/Revenue

    1.40

  • Enterprise Value/EBITDA

    8.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -14.82%

  • Return on Assets (ttm)

    0.86%

  • Return on Equity (ttm)

    -17.86%

  • Revenue (ttm)

    1.36B

  • Net Income Avi to Common (ttm)

    -206.4M

  • Diluted EPS (ttm)

    -0.4000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    89.97M

  • Total Debt/Equity (mrq)

    97.55%

  • Levered Free Cash Flow (ttm)

    -56.33M

Research Analysis: CURA.TO

View More

People Also Watch